Sun, Jia-Ning
Yang, Rui
Jiang, Xiao-Lu
Zhang, Feng
Zhao, Hong-Wei
Funding for this research was provided by:
Taishan Scholars Program of Shandong Province (tsqn202211379)
Major Science and Technology Project of Shandong Antibody Drug Innovation and Entrepreneurship Community in 2023
the National Natural Science Foundation of China (81972376)
Article History
Received: 12 December 2023
Accepted: 7 August 2024
First Online: 29 August 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Yuhuangding Hospital Ethics Committee. Written informed consent was obtained by the participants.
: Informed consent for publication was obtained from the participants.
: The authors declare no competing interests.